The recent spike in the COVID-19 hospitalisations of fully vaccinated patients in New South Wales (NSW) has prompted concerns of a loss in the efficacy of existing vaccines against the Omicron variant of the CCP virus. This comes after NSW recorded a greater number of double-dose vaccinated individuals presenting to hospitals with COVID-19 than those who were unvaccinated, although the data showed that unvaccinated were still more likely to end up in hospital because a higher proportion amongst the unvaccinated population had been admitted. Pfizer CEO Albert Bourla outlined the company would have a new vaccine ready in March capable of better handling new strains, such as Omicron, than its predecessor.  “We know that the two doses of the (existing) vaccine offer very limited protection, if any,” Bourla told Yahoo! News on Jan. 10. Bourla also stated that a third dose of the current vaccine only offered “reasonable protection against hospitalisation and …